IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population

Mikkel Andreassen; Ilan Raymond; Caroline Kistorp; Per Hildebrandt; Jens Faber; Lars Østergaard Kristensen; Mikkel Andreassen; Ilan Raymond; Caroline Kistorp; Per Hildebrandt; Jens Faber; Lars Østergaard Kristensen

doi:10.1530/EJE-08-0452

IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population

Mikkel Andreassen, Ilan Raymond, Caroline Kistorp, Per Hildebrandt, Jens Faber, Lars Østergaard Kristensen, Mikkel Andreassen, Ilan Raymond, Caroline Kistorp, Per Hildebrandt, Jens Faber, Lars Østergaard Kristensen

80 Citations (Scopus)

Abstract

BACKGROUND: IGF1 is believed to influence ageing and development of cardiovascular disease (CVD) through complex mechanisms. Reduced IGF1 levels might be causally associated with conditions accompanying ageing including development of CVD. However, in animal models reduced GH-IGF1 signalling increases lifespan. Reduced IGF1 activity might also be associated with longevity in humans. OBJECTIVE: The objective was to investigate if plasma IGF1 levels were associated with all cause mortality, and the development of chronic heart failure (CHF) and a major CV event. PATIENTS AND DESIGN: A population based study of 642 individuals, aged 50-89 years. Development of CHF was evaluated in 576 individuals with normal systolic function assessed by echocardiography and without the history of CHF or myocardial infarction. Development of the first major CV event was evaluated in 504 individuals with normal systolic function and without prevalent CVD. Outcomes were ascertained after 5 years using hospital discharge diagnoses. RESULTS: Adjustment for risk factors IGF1 values in the fourth quartile versus values below the fourth quartile was associated with increased mortality (n=103), hazard ratio (HR) 1.52 (95% confidence interval (CI) 1.01-2.28; P=0.044). IGF1 in the fourth quartile was also independently associated with risk of development of CHF (n=19), HR 5.02 (95% CI 2.00-12.64; P=0.001) but showed no association with the overall incidence of major CV events (n=58), HR 1.05 (95% CI 0.59-1.90; P=0.861). CONCLUSIONS: High IGF1 levels were independently associated with increased all cause mortality and risk of development of CHF, whereas no relation with the overall incidence of CVD was observed.

Original language	English
Journal	European Journal of Endocrinology
Volume	160
Issue number	1
Pages (from-to)	25-31
Number of pages	6
ISSN	0804-4643
DOIs	https://doi.org/10.1530/EJE-08-0452 https://doi.org/10.1530/EJE-08-0452
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

Cite this

Andreassen, M., Raymond, I., Kistorp, C., Hildebrandt, P., Faber, J., Kristensen, L. Ø., Andreassen, M., Raymond, I., Kistorp, C., Hildebrandt, P., Faber, J., & Kristensen, L. Ø. (2009). IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population. European Journal of Endocrinology, 160(1), 25-31. https://doi.org/10.1530/EJE-08-0452, https://doi.org/10.1530/EJE-08-0452

Andreassen, M, Raymond, I, Kistorp, C, Hildebrandt, P, Faber, J, Kristensen, LØ, Andreassen, M, Raymond, I, Kistorp, C, Hildebrandt, P, Faber, J & Kristensen, LØ 2009, 'IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population', European Journal of Endocrinology, vol. 160, no. 1, pp. 25-31. https://doi.org/10.1530/EJE-08-0452, https://doi.org/10.1530/EJE-08-0452

@article{56506420072f11de8478000ea68e967b,

title = "IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population",

abstract = "BACKGROUND: IGF1 is believed to influence ageing and development of cardiovascular disease (CVD) through complex mechanisms. Reduced IGF1 levels might be causally associated with conditions accompanying ageing including development of CVD. However, in animal models reduced GH-IGF1 signalling increases lifespan. Reduced IGF1 activity might also be associated with longevity in humans. OBJECTIVE: The objective was to investigate if plasma IGF1 levels were associated with all cause mortality, and the development of chronic heart failure (CHF) and a major CV event. PATIENTS AND DESIGN: A population based study of 642 individuals, aged 50-89 years. Development of CHF was evaluated in 576 individuals with normal systolic function assessed by echocardiography and without the history of CHF or myocardial infarction. Development of the first major CV event was evaluated in 504 individuals with normal systolic function and without prevalent CVD. Outcomes were ascertained after 5 years using hospital discharge diagnoses. RESULTS: Adjustment for risk factors IGF1 values in the fourth quartile versus values below the fourth quartile was associated with increased mortality (n=103), hazard ratio (HR) 1.52 (95% confidence interval (CI) 1.01-2.28; P=0.044). IGF1 in the fourth quartile was also independently associated with risk of development of CHF (n=19), HR 5.02 (95% CI 2.00-12.64; P=0.001) but showed no association with the overall incidence of major CV events (n=58), HR 1.05 (95% CI 0.59-1.90; P=0.861). CONCLUSIONS: High IGF1 levels were independently associated with increased all cause mortality and risk of development of CHF, whereas no relation with the overall incidence of CVD was observed.",

author = "Mikkel Andreassen and Ilan Raymond and Caroline Kistorp and Per Hildebrandt and Jens Faber and Kristensen, {Lars {\O}stergaard} and Mikkel Andreassen and Ilan Raymond and Caroline Kistorp and Per Hildebrandt and Jens Faber and Kristensen, {Lars {\O}stergaard}",

note = "Keywords: Aged; Aged, 80 and over; Cardiovascular Diseases; Cohort Studies; Denmark; Female; Humans; Insulin-Like Growth Factor I; Kaplan-Meiers Estimate; Male; Middle Aged; Prospective Studies",

year = "2009",

doi = "10.1530/EJE-08-0452",

language = "English",

volume = "160",

pages = "25--31",

journal = "European Journal of Endocrinology",

issn = "0804-4643",

publisher = "BioScientifica Ltd.",

number = "1",

}

TY - JOUR

T1 - IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population

AU - Andreassen, Mikkel

AU - Raymond, Ilan

AU - Kistorp, Caroline

AU - Hildebrandt, Per

AU - Faber, Jens

AU - Kristensen, Lars Østergaard

AU - Andreassen, Mikkel

AU - Raymond, Ilan

AU - Kistorp, Caroline

AU - Hildebrandt, Per

AU - Faber, Jens

AU - Kristensen, Lars Østergaard

N1 - Keywords: Aged; Aged, 80 and over; Cardiovascular Diseases; Cohort Studies; Denmark; Female; Humans; Insulin-Like Growth Factor I; Kaplan-Meiers Estimate; Male; Middle Aged; Prospective Studies

PY - 2009

Y1 - 2009

N2 - BACKGROUND: IGF1 is believed to influence ageing and development of cardiovascular disease (CVD) through complex mechanisms. Reduced IGF1 levels might be causally associated with conditions accompanying ageing including development of CVD. However, in animal models reduced GH-IGF1 signalling increases lifespan. Reduced IGF1 activity might also be associated with longevity in humans. OBJECTIVE: The objective was to investigate if plasma IGF1 levels were associated with all cause mortality, and the development of chronic heart failure (CHF) and a major CV event. PATIENTS AND DESIGN: A population based study of 642 individuals, aged 50-89 years. Development of CHF was evaluated in 576 individuals with normal systolic function assessed by echocardiography and without the history of CHF or myocardial infarction. Development of the first major CV event was evaluated in 504 individuals with normal systolic function and without prevalent CVD. Outcomes were ascertained after 5 years using hospital discharge diagnoses. RESULTS: Adjustment for risk factors IGF1 values in the fourth quartile versus values below the fourth quartile was associated with increased mortality (n=103), hazard ratio (HR) 1.52 (95% confidence interval (CI) 1.01-2.28; P=0.044). IGF1 in the fourth quartile was also independently associated with risk of development of CHF (n=19), HR 5.02 (95% CI 2.00-12.64; P=0.001) but showed no association with the overall incidence of major CV events (n=58), HR 1.05 (95% CI 0.59-1.90; P=0.861). CONCLUSIONS: High IGF1 levels were independently associated with increased all cause mortality and risk of development of CHF, whereas no relation with the overall incidence of CVD was observed.

AB - BACKGROUND: IGF1 is believed to influence ageing and development of cardiovascular disease (CVD) through complex mechanisms. Reduced IGF1 levels might be causally associated with conditions accompanying ageing including development of CVD. However, in animal models reduced GH-IGF1 signalling increases lifespan. Reduced IGF1 activity might also be associated with longevity in humans. OBJECTIVE: The objective was to investigate if plasma IGF1 levels were associated with all cause mortality, and the development of chronic heart failure (CHF) and a major CV event. PATIENTS AND DESIGN: A population based study of 642 individuals, aged 50-89 years. Development of CHF was evaluated in 576 individuals with normal systolic function assessed by echocardiography and without the history of CHF or myocardial infarction. Development of the first major CV event was evaluated in 504 individuals with normal systolic function and without prevalent CVD. Outcomes were ascertained after 5 years using hospital discharge diagnoses. RESULTS: Adjustment for risk factors IGF1 values in the fourth quartile versus values below the fourth quartile was associated with increased mortality (n=103), hazard ratio (HR) 1.52 (95% confidence interval (CI) 1.01-2.28; P=0.044). IGF1 in the fourth quartile was also independently associated with risk of development of CHF (n=19), HR 5.02 (95% CI 2.00-12.64; P=0.001) but showed no association with the overall incidence of major CV events (n=58), HR 1.05 (95% CI 0.59-1.90; P=0.861). CONCLUSIONS: High IGF1 levels were independently associated with increased all cause mortality and risk of development of CHF, whereas no relation with the overall incidence of CVD was observed.

U2 - 10.1530/EJE-08-0452

DO - 10.1530/EJE-08-0452

M3 - Journal article

C2 - 18931092

SN - 0804-4643

VL - 160

SP - 25

EP - 31

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

IS - 1

ER -

IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this